Autopsy report · NCT05409183
Effectiveness of CRD-740 in Heart Failure
Cause of deathOther
“Part A of the study was successfully concluded. Part B of the study was not conducted in favor of redesigned new studies.”
Life of this trial
- Ran for about 1 year 2 months before it stopped.
- 60 participants enrolled.
- Results were posted on the registry 1 year 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Cardurion Pharmaceuticals, Inc.
- Sponsor type
- Industry
- Conditions
- Heart Failure; Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction; Cardiovascular Diseases; Heart Diseases
- Interventions
- CRD-740; Placebo
- Participants
- 60
- Sites
- 34
- Countries
- Canada, Israel, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.